Risk assessment: Outbreak of Shiga toxin-producing E. coli (STEC) in Germany
At the request of the European Commission’s Directorate-General for Health and Consumers, a rapid risk assessment has been prepared concerning the outbreak of E Coli in Germany.
Shiga toxin/verotoxin-producing Escherichia coli in humans, food and animals in the EU/EEA, with special reference to the German outbreak strain STEC O104
This joint report, produced by the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA), aims to give a short summary of reported Shiga toxin/verotoxin-producing Escherichia coli (STEC/VTEC) prevalence and incidence in humans, food and animals.
Outbreak of Shiga toxin-producing E. coli (STEC) in Germany, May 2011
Shiga toxin-producing E. coli (STEC) is a group of pathogenic Escherichia coli strains capable of producing Shiga toxins, with the potential to cause severe enteric and systemic disease in humans.
Revised risk assessment: Outbreak of Shiga toxin-producing E. coli (STEC) in Germany
An update of the initial rapid risk assessment on the outbreak of E. Coli in Germany, prepared at the request of the European Commission, first published on 27 May 2011.
Risk assessment: Autochthonous Plasmodium vivax malaria in Greece
Greece reports six cases of Plasmodium vivax infection in Evrotas, Lakonia, Peloponnese region, and Chalkida in Evoia since June 2011. The main risk related to the current event is to persons living in, visiting and working in the particular area of Evrotas in the district of Lakonia (and potentially Chalkida in Evoia, though more information is needed) in Greece.
Rapid risk assessment: Update on autochthonous Plasmodium vivax malaria in Greece
The ECDC risk, as assessed on 23 August 2011, remains unchanged. The main risk is to persons residing in, visiting and working in the affected areas of Greece, particularly Evrotas in Lakonia. The risk for further extension of malaria transmission into the EU as a result of this event is considered low at present. EU national blood competent authorities should be considering whether to implement deferral measures for persons returning from these specific affected areas in Greece, taking into consideration measures currently implemented by the Greek blood safety authorities and after a considered risk assessment in collaboration with their national public health authorities.
ECDC rapid risk assessment: First isolation of a secondary oseltamivir-resistant A(H1N1)v strain in Denmark
ECDC rapid risk assessment: Influenza of possible swine origin in human in Spain
Influenza of swine origin detected retrospectively in a human with illness in November 2008. Swine influenza (SI) is an acute viral infection of the respiratory tract in pigs. Subclinical infections are also common. The mortality is low and recovery usually occurs within 7-10 days.
Risk assessment: New Orthobunyavirus isolated from infected cattle and small livestock ─ potential implications for human health
Based on current evidence, it is not possible to confirm or exclude a causal relationship between detection of the new orthobunyavirus and the observed clinical symptoms in cattle and small livestock.